215 related articles for article (PubMed ID: 29953544)
21. Excretion/secretion products from Schistosoma mansoni adults, eggs and schistosomula have unique peptidase specificity profiles.
Dvořák J; Fajtová P; Ulrychová L; Leontovyč A; Rojo-Arreola L; Suzuki BM; Horn M; Mareš M; Craik CS; Caffrey CR; O'Donoghue AJ
Biochimie; 2016 Mar; 122():99-109. PubMed ID: 26409899
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of the Schistosoma mansoni zinc finger protein SmZF1 as a transcription factor.
Drummond MG; Calzavara-Silva CE; D'Astolfo DS; Cardoso FC; Rajão MA; Mourão MM; Gava E; Oliveira SC; Macedo AM; Machado CR; Pena SD; Kitten GT; Franco GR
PLoS Negl Trop Dis; 2009 Nov; 3(11):e547. PubMed ID: 19901992
[TBL] [Abstract][Full Text] [Related]
23. The role of the adaptor molecule STING during Schistosoma mansoni infection.
Souza C; Sanches RCO; Assis NRG; Marinho FV; Mambelli FS; Morais SB; Gimenez EGT; Guimarães ES; Castro TBR; Oliveira SC
Sci Rep; 2020 May; 10(1):7901. PubMed ID: 32404867
[TBL] [Abstract][Full Text] [Related]
24. The esophageal gland mediates host immune evasion by the human parasite
Lee J; Chong T; Newmark PA
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19299-19309. PubMed ID: 32737161
[TBL] [Abstract][Full Text] [Related]
25. Schistosoma mansoni: TGF-beta signaling pathways.
Loverde PT; Osman A; Hinck A
Exp Parasitol; 2007 Nov; 117(3):304-17. PubMed ID: 17643432
[TBL] [Abstract][Full Text] [Related]
26. A single dose of the antineoplastics hydroxyurea or cisplatin has praziquantel-like effects on Schistosoma mansoni worms and host mouse liver.
Eldeeb E; Fahmy S; Elbakry K; Hyder A
Biomed Pharmacother; 2018 Mar; 99():570-575. PubMed ID: 29902867
[TBL] [Abstract][Full Text] [Related]
27. Schistosoma mansoni oviposition in vitro reflects worm fecundity in vivo: individual-, parasite age- and host-dependent variations.
el Ridi R; Ozaki T; Inaba T; Ito M; Kamiya H
Int J Parasitol; 1997 Apr; 27(4):381-7. PubMed ID: 9184930
[TBL] [Abstract][Full Text] [Related]
28. Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses.
Fitzpatrick JM; Peak E; Perally S; Chalmers IW; Barrett J; Yoshino TP; Ivens AC; Hoffmann KF
PLoS Negl Trop Dis; 2009 Nov; 3(11):e543. PubMed ID: 19885392
[TBL] [Abstract][Full Text] [Related]
29. Discovery of Potent Inhibitors of Schistosoma mansoni NAD⁺ Catabolizing Enzyme.
Jacques SA; Kuhn I; Koniev O; Schuber F; Lund FE; Wagner A; Muller-Steffner H; Kellenberger E
J Med Chem; 2015 Apr; 58(8):3582-92. PubMed ID: 25803425
[TBL] [Abstract][Full Text] [Related]
30. Methods for Studying the Germline of the Human Parasite Schistosoma mansoni.
Collins JN; Collins JJ
Methods Mol Biol; 2017; 1463():35-47. PubMed ID: 27734345
[TBL] [Abstract][Full Text] [Related]
31. The Schistosoma mansoni Cytochrome P450 (CYP3050A1) Is Essential for Worm Survival and Egg Development.
Ziniel PD; Karumudi B; Barnard AH; Fisher EM; Thatcher GR; Podust LM; Williams DL
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004279. PubMed ID: 26713732
[TBL] [Abstract][Full Text] [Related]
32. Evidence for Integrin - Venus Kinase Receptor 1 Alliance in the Ovary of Schistosoma mansoni Females Controlling Cell Survival.
Gelmedin V; Morel M; Hahnel S; Cailliau K; Dissous C; Grevelding CG
PLoS Pathog; 2017 Jan; 13(1):e1006147. PubMed ID: 28114363
[TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase.
You H; Mayer JU; Johnston RL; Sivakumaran H; Ranasinghe S; Rivera V; Kondrashova O; Koufariotis LT; Du X; Driguez P; French JD; Waddell N; Duke MG; Ittiprasert W; Mann VH; Brindley PJ; Jones MK; McManus DP
FASEB J; 2021 Jan; 35(1):e21205. PubMed ID: 33337558
[TBL] [Abstract][Full Text] [Related]
34. Sm16, A
Bernardes WPOS; de Araújo JM; Carvalho GB; Alves CC; de Moura Coelho AT; Dutra ITS; Teixeira SSF; de Azambuja Ribeiro RIM; de Moraes Mourão M; da Silva-Pereira RA; Fonseca CT
J Immunol Res; 2019; 2019():6793596. PubMed ID: 31886307
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasis.
Carneiro VC; de Abreu da Silva IC; Torres EJ; Caby S; Lancelot J; Vanderstraete M; Furdas SD; Jung M; Pierce RJ; Fantappié MR
PLoS Pathog; 2014 May; 10(5):e1004116. PubMed ID: 24809504
[TBL] [Abstract][Full Text] [Related]
36. Large-scale RNAi screening uncovers therapeutic targets in the parasite
Wang J; Paz C; Padalino G; Coghlan A; Lu Z; Gradinaru I; Collins JNR; Berriman M; Hoffmann KF; Collins JJ
Science; 2020 Sep; 369(6511):1649-1653. PubMed ID: 32973031
[TBL] [Abstract][Full Text] [Related]
37. Spatial expression pattern of serine proteases in the blood fluke Schistosoma mansoni determined by fluorescence RNA in situ hybridization.
Ulrychová L; Ostašov P; Chanová M; Mareš M; Horn M; Dvořák J
Parasit Vectors; 2021 May; 14(1):274. PubMed ID: 34022917
[TBL] [Abstract][Full Text] [Related]
38. Effects of Schistosoma mansoni worms and eggs on circulating cholesterol and liver lipids in mice.
Stanley RG; Jackson CL; Griffiths K; Doenhoff MJ
Atherosclerosis; 2009 Nov; 207(1):131-8. PubMed ID: 19464685
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA levels can be modulated by 5-azacytidine in Schistosoma mansoni.
Amaral MS; Maciel LF; Silveira GO; Olberg GGO; Leite JVP; Imamura LK; Pereira ASA; Miyasato PA; Nakano E; Verjovski-Almeida S
Sci Rep; 2020 Dec; 10(1):21565. PubMed ID: 33299037
[TBL] [Abstract][Full Text] [Related]
40. The Schistosoma mansoni genome encodes thousands of long non-coding RNAs predicted to be functional at different parasite life-cycle stages.
Vasconcelos EJR; daSilva LF; Pires DS; Lavezzo GM; Pereira ASA; Amaral MS; Verjovski-Almeida S
Sci Rep; 2017 Sep; 7(1):10508. PubMed ID: 28874839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
